1.
Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak.
2.
3.
The value of seroprevalence data as surveillance tool for Lyme borreliosis in the general population: the experience of Belgium.
4.
5.
6.
7.